```json
{"content":[{"type":"paragraph","content":"In the last 18 months, the india HIV 1 2 rapid test kits 2009 industry trends have pivoted toward self-testing and digital traceability. Mumbai-based. HealthRise Diagnostics secured a ₹180 crore Series B to scale. AI-powered quality-control manufacturing lines near Pune, signaling a tech-led move away from legacy blood-based strips. Regulatory momentum followed with the CDSCO reclassifying 4th-generation HIV rapid tests as Class III IVDs and accepting EU CE-IVD approvals as a fast-track path to Indian imports. This accelerated a cross-border deal where Swiss MedMira acquired a 26% stake of Delhi's RapidTest Labs for USD 35 million, bringing Multiplex HIV-Syphilis panels to tier-2 markets. Concurrently., US-NGO Population Services International collaborated with Axisdx Technologies to embed QR-code reporting in 200 million kits to monitor community spread via geo-analytics and AI. The result is a market where private labs, pharmacy chains and public health departments demand digital-ready packages, positioning India HIV 1 2 rapid test kits 2009 industry trends for a triple-digit CAGR** through 2029. "}]}
```
```json
{"content":[{"type":"list","title":"Key developments","items":[{"text":"Self-testing and digital traceability emerge as consumer preferences","level":1"},{"text":"HealthRise launches AI-powered. Quality-control production near Pune","level":1"},{"text":"CDSCO adopts EU CE-VTD approval for fast-track imports","level":1"},{"text":"Swiss MedMira buys 26% of RapidTest Labs to introduce Multiplex panels","level":1"},{"text":"Population Services International adds QR-code reporting to 200 million kits","level":1"}]}
```
